Ciliate Expression of Mammalian Voltage-Gated Ion Channels
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for expressing voltage-gated ion channels in mammalian cells result in low levels of correctly folded and surface-localized proteins, limiting the availability of high-density ion channels for drug discovery and therapeutic development, particularly for small molecule screening and monoclonal antibody production.
Innovation Solution
Transgenic ciliates, such as Tetrahymena thermophila, are engineered to express mammalian voltage-gated ion channels with optimized codon usage and regulatory sequences, achieving high levels of correct folding and membrane integration, enabling the production of membrane preparations with high densities of functional ion channels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If voltage-gated ion channels are expressed in mammalian cells using traditional methods, then the expression system is well-established and easy to operate, but the levels of correctly folded and surface-localized proteins are low
Solution Approach 1:
The patent changes the host cell parameter from mammalian cells to ciliate cells (Tetrahymena thermophila), which fundamentally alters the cellular environment and protein processing capabilities. This parameter change enables higher expression levels of correctly folded voltage-gated ion channels at the cell surface, resolving the contradiction between reliability of folding and productivity of expression.
2Quantity of substance
If more voltage-gated ion channels are produced to achieve high density, then the availability for drug discovery improves, but the complexity of achieving correct folding and membrane integration increases
Solution Approach 1:
The ciliate expression system possesses endogenous capabilities for correct protein folding and membrane integration that automatically service the production of voltage-gated ion channels. The system self-regulates the complex processes of folding and membrane integration without requiring additional external intervention, enabling high ion channel density while managing complexity through the host's natural machinery.
3Manufacturing precision
If traditional mammalian expression systems are used, then the process is straightforward, but the purity and density of functional ion channels are insufficient for effective drug screening
Solution Approach 1:
By changing the host organism parameter from mammalian to ciliate cells, the patent achieves superior manufacturing precision in terms of ion channel purity and density. Although this introduces some complexity in establishing the expression system, the ciliate system's natural properties facilitate high-level production of correctly folded, functional channels that meet drug screening requirements.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Methods are disclosed for the production of mammalian voltage-gated ion channels in ciliates. In other aspects, compositions comprising lipid bilayers containing mammalian voltage-gated ion channels are disclosed. In other aspects, compositions comprising purified and reconstituted mammalian voltage-gated ion channels are disclosed.